StockNews.com assumed coverage on shares of Oxbridge Re (NASDAQ:OXBR – Free Report) in a research report sent to investors on Thursday morning. The firm issued a hold rating on the insurance provider’s stock.
Oxbridge Re Trading Down 0.4 %
Oxbridge Re stock opened at $2.79 on Thursday. Oxbridge Re has a 52 week low of $0.87 and a 52 week high of $3.72. The business’s 50-day simple moving average is $2.51 and its 200-day simple moving average is $2.00.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The insurance provider reported ($0.14) earnings per share (EPS) for the quarter. The business had revenue of $0.04 million during the quarter.
Insider Activity at Oxbridge Re
Institutional Investors Weigh In On Oxbridge Re
A hedge fund recently raised its stake in Oxbridge Re stock. Henrickson Nauta Wealth Advisors Inc. lifted its stake in Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) by 50.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,000 shares of the insurance provider’s stock after acquiring an additional 5,000 shares during the quarter. Henrickson Nauta Wealth Advisors Inc. owned 0.25% of Oxbridge Re worth $36,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 5.64% of the company’s stock.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology.
See Also
- Five stocks we like better than Oxbridge Re
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- MarketBeat Week in Review – 9/23 – 9/27
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.